Pentobarbital

Pentobarbital

SCHEMBL735353

CCC[C@H](C)C1(CC)C(=O)NC(=O)NC1=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQ

The experimentally established mechanism targets of Pentobarbital. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GABRB3 known ✓ P28472 1/20 1.00
GABRA2 known ✓ P47869 1/20 1.00
GABRB2 known ✓ P47870 1/20 1.00
CYP3A4 P08684 3/20 1.00
ALDH1A1 P00352 2/20 1.00
KDM4E B2RXH2 1/20 1.00
OPRD1 P41143 1/20 1.00
LMNA P02545 5/20 0.73
MMP9 P14780 4/20 0.67
RECQL P46063 1/20 0.49
NR1I2 O75469 1/20 0.43
POLB P06746 1/20 0.41
PKM P14618 1/20 0.41
CYP19A1 P11511 1/20 0.34
TP53 P04637 1/20 0.32
MMP2 P08253 2/20 0.32
MMP3 P08254 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pentobarbital SCHEMBL2376470 1.00 CYP3A4 (1.00) CYP3A4ALDH1A1KDM4EGABRB3OPRD1
Pentobarbital SCHEMBL24966 1.00 CYP3A4 (1.00) CYP3A4ALDH1A1KDM4EGABRB3OPRD1
Pentobarbital SCHEMBL26057 0.98 CYP3A4 (0.96) CYP3A4ALDH1A1KDM4EGABRB3OPRD1
Pentobarbital SCHEMBL4207760 0.98 CYP3A4 (0.96) CYP3A4ALDH1A1KDM4EGABRB3OPRD1
Pentobarbital SCHEMBL7639355 0.98 CYP3A4 (0.96) CYP3A4ALDH1A1KDM4EGABRB3OPRD1
Pentobarbital SCHEMBL1256614 0.98 CYP3A4 (0.96) CYP3A4ALDH1A1KDM4EGABRB3OPRD1
Pentobarbital SCHEMBL3695587 0.98 CYP3A4 (0.96) CYP3A4ALDH1A1KDM4EGABRB3OPRD1
Pentobarbital SCHEMBL26056 0.98 CYP3A4 (0.96) CYP3A4ALDH1A1KDM4EGABRB3OPRD1
Pentobarbital SCHEMBL3245534 0.98 CYP3A4 (0.96) CYP3A4ALDH1A1KDM4EGABRB3OPRD1
Pentobarbital SCHEMBL30173355 0.98 CYP3A4 (0.96) CYP3A4ALDH1A1KDM4EGABRB3OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1559 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240282425-A1 AUTHENTICATION METHODS AND SYSTEMS FOR DISPENSED PRESCRIPTIONS LOW GORDON KEITH (US) 2024-08-22 US claimed
US-20200345722-A1 ABUSE-DETERRENT DRUG FORMULATIONS COLLEGIUM PHARMACEUTICAL INC (US) 2020-11-05 US claimed
US-20200345723-A1 ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS COLLEGIUM PHARMACEUTICAL INC (US) 2020-11-05 US claimed
US-20200093820-A1 ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS COLLEGIUM PHARMACEUTICAL, INC. (US) 2020-03-26 US claimed
US-20200093819-A1 ABUSE-DETERRENT DRUG FORMULATIONS COLLEGIUM PHARMACEUTICAL, INC. 2020-03-26 US claimed
CN-109568337-A A kind of keratitis animal model preparation method and application 成都合拓创展生物科技有限公司 2019-04-05 CN claimed
CN-109453155-A For assessing the construction method of the tree shrew model of anti-influenza virus medicament pharmacokinetics and pharmacodynamics 广州医科大学附属第医院 2019-03-12 CN claimed
CN-109439613-A MICE FETAL LIVER stroma cell construction method and its application in hematopoiesis auxiliary 上海市儿童医院 2019-03-08 CN claimed
CN-109224070-A The construction method of influenza B virus tree shrew model 广州医科大学附属第医院 2019-01-18 CN claimed
EP-3326617-A1 ABUSE-DETERRENT DRUG FORMULATIONS Collegium Pharmaceutical, Inc. (US) 2018-05-30 EP claimed
US-20090297617-A1 ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS COLLEGIUM PHARMACEUTICALS INC. 2009-12-03 US claimed
EP-1594467-A4 ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS COLLEGIUM PHARMACEUTICAL INC (US) 2008-10-22 EP claimed
US-7399488-B2 Abuse-deterrent pharmaceutical compositions of opiods and other drugs COLLEGIUM PHARMACEUTICAL, INC. (US) 2008-07-15 US claimed
EP-1765292-A1 ABUSE-DETERRENT DRUG FORMULATIONS Collegium Pharmaceutical, Inc. (US) 2007-03-28 EP claimed
WO-2005123039-A1 ABUSE-DETERRENT DRUG FORMULATIONS COLLEGIUM PHARMACEUTICAL, INC. (US) 2005-12-29 WO claimed
US-20050281748-A1 Abuse-deterrent drug formulations COLLEGIUM PHARMACEUTICAL, INC. 2005-12-22 US claimed
EP-1594467-A1 ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS Collegium Pharmaceutical, Inc. (US) 2005-11-16 EP claimed
US-20040052731-A1 Abuse-deterrent pharmaceutical compositions of opiods and other drugs COLLEGIUM PHARMACEUTICALS, INC. 2004-03-18 US claimed
WO-2004004693-A1 ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS OF OPIODS AND OTHER DRUGS COLLGEGIUM PHARMACEUTICAL (US) 2004-01-15 WO claimed
EP-0408496-A2 Solid dosage form for pharmaceutical substances CIBA-GEIGY AG (CH) 1991-01-16 EP claimed